(Q73747204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

lymphoblastic leukemia

1 reference

A M Leahey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N J Bunin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J B Belasco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Meek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Scher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B J Lange

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

313-318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report fro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Etoposide and cytosine arabinoside combination chemotherapy for refractory acute lymphocytic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28200005%2934%3A5%3C313%3A%3AAID-MPO1%3E3.0.CO%3B2-Q

10.1002/(SICI)1096-911X(200005)34:5<313::AID-MPO1>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10797352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference